The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the Johns Hopkins Applied Physics Laboratory (APL) and a team of collaborators underscores that principle.
Regulus raises $100M; Cancer company files to go public
Plus, news about RF Acquisition Corp II, Skye Bioscience, Cognition Therapeutics, Siolta Therapeutics and Tierra Biosciences: Regulus Therapeutics’ PhI data and $100M raise: The company’s